Mallinckrodt plc (the “Company”) has
received unsolicited letters on behalf of various parties holding substantial positions across the Company’s capital structure,
including certain holders of the Company’s (i) terms loans due 2027 issued under the Credit Agreement, dated as of June 16,
2022 (the “Term Loan Holders”), (ii) 10.000% first lien senior secured notes due 2025 (“2025 First Lien Notes”),
(iii) 11.500% first lien senior secured notes due 2028, (iv) 10.000% second lien senior secured notes due 2025 (“2025
Second Lien Notes”), and (v) 10.000% second lien senior secured notes due 2029 (such holders described in clauses (i) through
(v), collectively, the “Holders”).
The
letters, the first of which was received on May 17, 2023, addressed various matters, including certain of the Holders’ views
regarding the Company’s financial position. The Holders requested that the Company’s board of directors (the “Board”)
and management team evaluate the Company’s financial wherewithal and consider alternative options to meet its financial responsibilities,
including, in the case of certain Holders, consideration of alternatives to making the $200 million payment required by the Company’s
opioid settlement to be made to the Opioid Master Disbursement Trust II (the “Trust”) on June 16, 2023. Certain of the
Holders proposed transactions to be implemented through a filing under Chapter 11 of the U.S. Bankruptcy Code, potentially involving a
sale of assets in accordance with Section 363 of the U.S. Bankruptcy Code, and other Holders and interested parties proposed transactions
that would not involve a bankruptcy filing. Prior to receipt of the letters from the Holders, in connection with the Company’s evaluation
of its capital needs in light of its obligations under the opioid settlement and its long-term
debt obligations, including the 2025 First Lien Notes and 2025 Second Lien Notes, the Company
had commenced preliminary discussions with the Trust about alternatives to the existing payment structure for the opioid settlement. On
June 1, 2023, after the Company received the letters referenced above, the Trust sent a letter to the Company demanding payment be
made timely and threatening action against the Company, its officers and directors.
The Board is actively evaluating this situation
and considering options, including transactions that have been proposed by the Holders and other Company stakeholders, as well as the
viewpoints of the various parties in interest. On June 2, 2023, the Board directed management and the Company’s advisors to
continue analyzing various proposals and engaging in discussions with various parties related to these options and viewpoints. There can
be no assurance of the outcome of this process, including whether or not the Company may make a filing in the near term or later under
the U.S. Bankruptcy Code or analogous foreign bankruptcy or insolvency laws.
Cautionary Statements Related to Forward-Looking Statements
Statements in this Current Report that are not
strictly historical, including statements regarding the Board’s ongoing evaluation and consideration of alternatives and related
actions and discussions, are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act
of 1995, and involve a number of risks and uncertainties.
There are a number of important factors that could
cause actual events to differ materially from those suggested or indicated by such forward-looking statements and you should not place
undue reliance on any such forward-looking statements. These factors include risks and uncertainties related to, among other things: changes
in the Company’s business strategy and performance; the Company’s ability to access the capital markets now or in the future;
the liquidity, results of operations and businesses of the Company and its subsidiaries; the possibility that the Company and/or certain
of its subsidiaries voluntarily initiate proceedings under Chapter 11 of U.S. Bankruptcy Code or foreign bankruptcy or insolvency laws
and the potential effects of the initiation of such proceedings and the resulting bankruptcy or insolvency process on the Company’s
liquidity, results of operations and business; governmental investigations and inquiries, regulatory actions and lawsuits; actions taken
by third parties, including Holders or the Trust; court actions; the Company’s ability to achieve expected benefits from its prior
restructuring activities; the Company’s substantial indebtedness, its ability to generate sufficient cash to reduce its indebtedness
and its potential need and ability to incur further indebtedness; the Company’s ability to generate sufficient cash to service indebtedness;
restrictions on the Company’s operations contained in the agreements governing the Company’s indebtedness; the impact of Irish
laws; and the risks, uncertainties and factors described in the “Risk Factors” and “Management's Discussion and Analysis
of Financial Condition and Results of Operations” sections of the Company’s Annual Report on Form 10-K for the fiscal
year ended December 30, 2022 and the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31,
2023, as filed with the SEC and available on the Company’s website at http://www.mallinckrodt.com and http://www.sec.gov.
The forward-looking statements made herein speak
only as of the date hereof and the Company does not assume any obligation to update or revise any forward-looking statement, whether as
a result of new information, future events and developments or otherwise, except as required by law.